DK142874B - Analogifremgangsmåde til fremstilling af dihydrolysergsyrederivater eller syreadditionssalte deraf. - Google Patents
Analogifremgangsmåde til fremstilling af dihydrolysergsyrederivater eller syreadditionssalte deraf. Download PDFInfo
- Publication number
- DK142874B DK142874B DK238571A DK238571A DK142874B DK 142874 B DK142874 B DK 142874B DK 238571 A DK238571 A DK 238571A DK 238571 A DK238571 A DK 238571A DK 142874 B DK142874 B DK 142874B
- Authority
- DK
- Denmark
- Prior art keywords
- acid
- methyl
- preparation
- compound
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
- C07D457/08—Lysergic acid amides in which the amide nitrogen is a member of a heterocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK583874A DK139068B (da) | 1970-05-18 | 1974-11-08 | Fremgangsmåde til fremstilling af dihydrolysergsyre- og -isolysergsyreforbindelser eller syreadditionssalte deraf. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUGO001135 | 1970-05-18 | ||
HUGO001135 | 1970-05-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK142874B true DK142874B (da) | 1981-02-16 |
DK142874C DK142874C (ja) | 1981-09-28 |
Family
ID=10996683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK238571A DK142874B (da) | 1970-05-18 | 1971-05-17 | Analogifremgangsmåde til fremstilling af dihydrolysergsyrederivater eller syreadditionssalte deraf. |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPS5634598B1 (ja) |
AT (1) | AT347047B (ja) |
CA (1) | CA924306A (ja) |
CH (2) | CH590277A5 (ja) |
CS (1) | CS179371B2 (ja) |
DE (1) | DE2124640C2 (ja) |
DK (1) | DK142874B (ja) |
GB (1) | GB1345546A (ja) |
NL (1) | NL172825C (ja) |
SE (2) | SE396753B (ja) |
SU (1) | SU400091A3 (ja) |
YU (1) | YU35770B (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU169073B (ja) * | 1974-05-28 | 1976-09-28 | ||
US4064249A (en) * | 1974-05-28 | 1977-12-20 | Richter Gedeon Vegyeszeti Gyar Rt. | Compounds with ergoline skeleton |
HU172649B (hu) * | 1975-04-24 | 1978-11-28 | Gyogyszerkutato Intezet | Sposob poluchenija novykh biologicheski aktivnykh lizergamidov |
DE3001752A1 (de) * | 1980-01-16 | 1981-07-30 | Schering Ag Berlin Und Bergkamen, 1000 Berlin | Verfahren zur herstellung von 8(alpha)-substituierten 6-methylergolinen |
NL189462C (nl) * | 1980-04-03 | 1993-04-16 | Erba Carlo Spa | Ergolinederivaten met antiprolactinische en/of antihypertensieve eigenschappen en farmaceutische preparaat daarvan. |
US4902691A (en) * | 1988-12-19 | 1990-02-20 | Eli Lilly And Company | Heteroalkylamides of (8-β)-1-alkyl-6-(substituted)ergolines useful for blocking 5HT2 receptors |
US4914107A (en) * | 1989-01-17 | 1990-04-03 | Eli Lilly And Company | Method for selectively blocking 5-HT2 receptors |
US5441961A (en) * | 1992-08-27 | 1995-08-15 | Eli Lilly And Company | Substituted cyclo or bicycloalkylamides of (8β)-6-(substituted) ergolines |
BR112017015487A2 (pt) | 2015-01-20 | 2018-01-30 | Xoc Pharmaceuticals Inc | Composto; composição; método de tratamento e/ou prevenção de enxaqueca, als, doença de alzheimer, doença de parkinson, distúrbios extrapirimidais, depressão, náusea, êmese, síndrome das pernas inquietas, insônia, agressão, doença de huntington, doença cardiopulmonar, fibrogênese, hipertensão arterial pulmonar, ansiedade, dependências a drogas, distonia, parassonia ou hiperlactinemia em um indivíduo; métodos de agonização dos receptores d2, 5-ht1d, 5-ht1a e 5-ht2c, em um indivíduo; método de antagonização do receptor d3 em um indivíduo; métodos de agonização seletiva dos receptores 5 -ht1d, e 5-ht2c, método de fornecimento de atividade de antagonista funcional no receptor 5 -ht2b ou no receptor 5-ht7, ou em ambos, em um indivíduo; método de fornecimento de atividade de antagonista funcional nos receptores adrenérgicos em um indivíduo |
JP2018502889A (ja) | 2015-01-20 | 2018-02-01 | エックスオーシー ファーマシューティカルズ インコーポレイテッドXoc Pharmaceuticals, Inc | イソエルゴリン化合物およびその使用 |
WO2018223065A1 (en) | 2017-06-01 | 2018-12-06 | Xoc Pharmaceuticals, Inc. | Ergoline derivatives for use in medicine |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT192546B (de) * | 1956-02-27 | 1957-10-25 | Anton Von Waldheim Chemisch Ph | Verfahren zur Herstellung von Dihydrolysergsäure und deren Derivaten |
-
1971
- 1971-05-12 SE SE619771A patent/SE396753B/xx unknown
- 1971-05-14 GB GB1502471A patent/GB1345546A/en not_active Expired
- 1971-05-17 DK DK238571A patent/DK142874B/da not_active IP Right Cessation
- 1971-05-17 YU YU122971A patent/YU35770B/xx unknown
- 1971-05-17 AT AT428771A patent/AT347047B/de not_active IP Right Cessation
- 1971-05-17 SU SU1658569A patent/SU400091A3/ru active
- 1971-05-18 CA CA113255A patent/CA924306A/en not_active Expired
- 1971-05-18 JP JP3303571A patent/JPS5634598B1/ja active Pending
- 1971-05-18 CS CS359871A patent/CS179371B2/cs unknown
- 1971-05-18 CH CH160875A patent/CH590277A5/xx not_active IP Right Cessation
- 1971-05-18 DE DE19712124640 patent/DE2124640C2/de not_active Expired
- 1971-05-18 NL NL7106834A patent/NL172825C/xx not_active IP Right Cessation
- 1971-05-18 CH CH731971A patent/CH567506A5/xx not_active IP Right Cessation
-
1974
- 1974-03-26 SE SE7404075A patent/SE416302B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
SE396753B (sv) | 1977-10-03 |
DE2124640A1 (de) | 1972-11-02 |
CS179371B2 (en) | 1977-10-31 |
CA924306A (en) | 1973-04-10 |
GB1345546A (en) | 1974-01-30 |
DK142874C (ja) | 1981-09-28 |
SU400091A3 (ja) | 1973-10-03 |
JPS5634598B1 (ja) | 1981-08-11 |
NL172825C (nl) | 1983-11-01 |
CH590277A5 (ja) | 1977-07-29 |
CH567506A5 (ja) | 1975-10-15 |
YU122971A (en) | 1980-10-31 |
SE416302B (sv) | 1980-12-15 |
YU35770B (en) | 1981-06-30 |
NL172825B (nl) | 1983-06-01 |
DE2124640C2 (de) | 1983-02-03 |
NL7106834A (ja) | 1971-11-22 |
ATA428771A (de) | 1978-04-15 |
AT347047B (de) | 1978-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5017582A (en) | Method of inducing a serotonin M receptor antagonist effect with N-quinuclidinyl-benzamides | |
US4826838A (en) | Analgesic carbocyclic and heterocyclic carbonylmethylene-and carbonylmethypipidines and-pyrrolidines | |
EP0418716B1 (de) | Neue Thienylcarbonsäureester von Aminoalkoholen, ihre Quaternierungsprodukte sowie die Herstellung und Verwendung dieser Verbindungen | |
JPH06135963A (ja) | 置換ベンジルアミノキヌクリジン | |
JPS5936675A (ja) | 二環性複素環式カルボン酸アザビシクロアルキルエステルまたはアミド | |
US3299072A (en) | Thebaine derivatives | |
JPH10509167A (ja) | 療法に用いるためのモルフィンおよびコデインの誘導体 | |
DE3750359T2 (de) | Ester des Hexahydro-8-hydroxy-2,6-methano-2H-chinolizin-3(4H)-ons und verwandte Verbindungen. | |
DK142874B (da) | Analogifremgangsmåde til fremstilling af dihydrolysergsyrederivater eller syreadditionssalte deraf. | |
DE68918802T2 (de) | Stickstoff enthaltende heterozyklische Derivate. | |
US2824875A (en) | Certificate of correction | |
DE2359536A1 (de) | 2,6-diaminonebularinderivate | |
DE3880022T2 (de) | Cycloalkylamide von (8beta)-1-alkyl-6-(substituierten) ergolinen. | |
US4855422A (en) | Process for the preparation of azoniaspironortropanol esters | |
DE2162011A1 (de) | Neue Derivate des Isoindoline, ihre Herstellung und diese enthaltende medizinische Zusammensetzungen | |
JPH06501031A (ja) | 2,14―ジ置換されたエルゴリン、その製造および医薬品中での使用 | |
EP0105131A1 (en) | 2-(Omega-alkylaminoalkyl)- and 2-(omega-dialkylaminoalkyl)-3-(4-X-benzylidene)-phthalimidines | |
US3901893A (en) | New dihydro-lysergic acid derivative | |
NO752192L (ja) | ||
KR20010024558A (ko) | 신경근육 이완제로서의 비스-4차 암모늄 유도체 | |
KR950014866B1 (ko) | 에르골리닐 헤테로사이클 | |
EP0001585B1 (de) | Piperazino-pyrrolobenzodiazepine, Verfahren zu ihrer Herstellung sowie pharmazeutische Präparate enthaltend diese Verbindungen | |
KR930000113B1 (ko) | 아조니아스피로노르트로판올 에스테르의 제조방법 | |
US3564049A (en) | Adamantane-(1)-carboxylic acid derivatives | |
RU2058985C1 (ru) | Производные индола, способ их получения и фармацевтическая композиция для лечения психических расстройств на их основе |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |